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Human mitogen-activated protein (MAP) kinase interacting kinase 1b (Mnk1b) is a splice variant of human Mnk1a, which has been identified
in our laboratory [A. O’Loghlen, V.M. Gonzalez, D. Pineiro, M.I. Perez-Morgado, M. Salinas, M.E. Martin, Identification and molecular
characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1, Exp. Cell Res. 299 (2004) 343–355]. Mnk1b has
much higher basal eIF4E kinase activity than Mnk1a. Because Mnk1b presents different features in its C-terminus with respect to Mnk1a, we have
studied in this paper the potential role of these structural differences in determining the higher basal eIF4E kinase activity as well as the subcellular
localization of Mnk1b. In this paper, we demonstrate that phosphorylation of the Thr209 and Thr214 in the activation loop of Mnk1b is necessary
for its activation. However, the different kinase activity between Mnk1a and Mnk1b is independent of the phosphorylation status of the activation
loop residues. By deletion of the C-terminal tail in Mnk1a, we confirmed that the absence of this sequence is not responsible for the higher eIF4E
kinase activity present in Mnk1b. Moreover, our findings support a crucial role of the 12 amino acids, particularly the Ala344, in the C-terminal
specific region of Mnk1b (Mnk1bSR), on the kinase activity of the protein.
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The MAP kinase interacting kinases (Mnks) belong to the
Ca2+/calmodulin-dependent kinase family (CaMK), in particu-
lar to kinase group F [1], although, like other CaMK group
members, they are not regulated by Ca2+/calmodulin. Mnks
were identified simultaneously in mouse [2] and in human [3] in
1997. In mouse, there are two different isoforms, Mnk1 and
Mnk2 [2]. In human, there are four isoforms, named Mnk1a,
Mnk1b, Mnk2a and Mnk2b. The isoforms Mnk1b and Mnk2b
arise from an alternatively spliced transcript of two human
genes [3–5]. All the Mnk isoforms have a nuclear localization⁎ Corresponding author. Tel.: +34 91 336 8388; fax: +34 91 336 9016.
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doi:10.1016/j.bbamcr.2007.05.009signal (NLS) in the N-terminal region which allows the kinase
to enter into the nucleus. Human Mnk1b and Mnk2b are
truncated isoforms lacking the MAP kinase binding motif
present in the C-terminal region of the other isoforms. Mnk1a
and Mnk2a are both primarily cytoplasmic, whereas Mnk1b and
Mnk2b localize partially to the nucleus. Mnk1a contains a
nuclear export signal (NES) that ensures its cytoplasmic
localization [6], whereas Mnk1b lacks this NES, being
cytoplasmic and nuclear [5]. Mnk2a and Mnk2b lack this
NES but other mechanisms ensure the cytoplasmic localization
of Mnk2a, whereas Mnk2b is largely nuclear [7]. All the Mnk
isoforms (human and mouse) contain a conserved catalytic
domain, where two important threonine residues in the
activation loop play a key role in kinase activity. However,
the crystal structures of human Mnk1 and Mnk2 kinase domain
have been recently reported in which these kinases show a
noncanonical extended activation segment and the ATP binding
pocket contains an Asp–Phe–Asp (DFD) motif instead the
canonical Asp–Phe–Gly (DFG) motif [8,9].
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both the mitogen activated extracellular signal-regulated protein
kinases (ERK) 1/2 as well as the stress-activated p38 MAP
kinases (p38 MAPKs) both in vitro and in vivo [2,3]. The only
well-characterized substrate for the Mnks is the eukaryotic
initiation factor 4E (eIF4E). eIF4E has been reported to be
physiologically phosphorylated on the residue Serine 209
following treatment of cells with growth factors, hormones
and mitogens [10–12]. It has also been found that inhibition of
ERK1/2 or p38 MAP kinase pathways leads to the abrogation of
eIF4E phosphorylation [13]. These correlations set the
precedent of Mnk1 being an eIF4E kinase in vivo. These
results have recently been corroborated by the fact that eIF4E is
completely dephosphorylated in knock-out mice for Mnk1 and
Mnk2 which do not exhibit any apparent phenotypical
consequence questioning a vital role of Mnk activity [14].
Results from our laboratory showed a significant diminution of
eIF4E phosphorylation in cells transfected with siRNAs
generated against human Mnk1 [15].
In the cytoplasm, eIF4E is required for cap-dependent
translation. Here, eIF4E binds the 5′ cap structure of the
eukaryotic cytoplasmic mRNAs and subsequently recruits the
given mRNA to the ribosome [16]. eIF4E is one of the
components of the eukaryotic initiation factor 4F (eIF4F). In
higher eukaryotes, eIF4F consists of three subunits: eIF4E,
eIF4A, an ATP-dependent RNA helicase, and eIF4G that serves
as a scaffold protein for the assembly of eIF4E and eIF4A. In
order to phosphorylate efficiently eIF4E, Mnks have to bind to
the C-terminal region of eIF4G [17]. The effect of eIF4E
phosphorylation on eIF4F activity is controversial. In some
papers phosphorylated eIF4E has been reported to have higher
binding affinity for the cap [18] and to form a more stable eIF4F
complex [19]. However, recent findings including ours, support
that eIF4E phosphorylation markedly reduces its affinity for
capped mRNA although different models have been proposed
[15,20,21]. In the nucleus, eIF4E promotes nuclear export of a
subset of specific mRNAs [22]. The Borden laboratory has
demonstrated that the phosphorylation of nuclear eIF4E seems
to be an important step in the control of the mRNA transport
[23]. Consistently, several findings support that eIF4E phos-
phorylation can play some role in the transport of cyclin D1
from the nucleus to the cytoplasm which drives to cellTable 1
Primers used for the cloning of the Mnk1a and Mnk1b mutants
Mutants Name
Mnk1a/b T2D2 209D214D5
209D214D3
Mnk1a/b T2A2 209A214A5
209A214A3
Mnk1b A344D Mnk1b344D5
Mnk1b344D3
Mnk1b A344T Mnk1b344T5
Mnk1b344T3
Mnk1aΔ77 5′Mnk1
3′Mnk1aΔ77
Mnk1aΔ89 5′Mnk1
3′Mnk1aΔ89transformation [23]. Moreover, it has been observed that the
treatment of the human breast cell line AU565 with the Mnk1
inhibitor CGP57380 reduces the colony formation in soft agar
[24].
Other substrates for the Mnks, such as phospholipase A2
[25] and hnRNP A1 [26], have been also reported. Moreover,
there is evidence that the Mnks play a key role in the control of
TNFα production and in the stress response, probably through
phosphorylation of hnRNPA1 that bind the regulatory AU-rich
elements (AREs) of the 3′UTR of its mRNAs [26,27].
Our earlier results demonstrate that human Mnk1b mRNA is
almost identical to human Mnk1 mRNA lacking a region
corresponding to exon 12, which causes a change in the reading
frame and generates a stop codon. The resulting protein lacks
the last 89 amino acid residues at the C-terminal region that are
replaced by 12 residues with an entirely new sequence, the
Mnk1b-specific region (Mnk1bSR). From the different features
in human Mnk1 isoforms, we have shown that Mnk1b has a
higher basal activity than Mnk1a. Moreover, Mnk1b activity
does not correlate with the phosphorylation of the activation
loop residues and seems to be independent of the upstream
kinases (ERK1/2 and p38 MAP kinase) [5]. Here, we illustrate
the biochemical characterization of human Mnk1b, including
the features that may be crucial for its basal activity, mainly the
Mnk1bSR.2. Materials and methods
2.1. Plasmids
Human Mnk1a and Mnk1b were obtained as described by O’Loghlen at al.
2004 [5]. The Mnk1b sequence data have the accession number AY355461 in
the GenBank database. Mnk1a and Mnk1b mutants Thr209Asp/Thr214Asp
(T2D2), Thr209Ala/Thr214Ala (T2A2) and Mnk1b mutants Ala344Asp
(A344D) and Ala344Thr (A344T) were created by PCR-mediated mutagenesis
in two steps and confirmed by nucleotide sequencing. The primers used to
generate the different mutations are listed in Table 1.
2.2. Cell culture and transient transfection
Human HEK293T cells were grown in 6-well plates in DMEM
supplemented with 10% fetal bovine serum at a cell density of 3×105 cells/
well and transfected using Lipofectamine 2000 (Invitrogen). After 24 h of
transfection, the medium was removed and the cells were washed twice with ice-Sequence
5′-ATAACCGACCCAGAGCTGACCGACCCATGT-3′
5′-ACATGGGTCGGTCAGCTCTGGGTCGGTTAT-3′
5′-ATAACCGCACCAGAGCTGACCGCCCCATGT-3′
5′-ACATGGGGCGGTCAGCTCTGGTGCGGTTAT-3′
5′-GGACCTGACGACCTTCGCAGC-3′
5′-GCTGCGAAGGTCGTCAGGTCC-3′
5′-GGACCTGACA CTCTTCGCAGC-3′
5′-GCTGCGAAGAGTGTCAGGTCC-3′
5′-GCCTCTAGAGTATCTTCTCAAAAGTTGGAA-3′
5′-GGCGAATTCTCAGAC TTGCGGCGTGGG-3′
5′-GCCTCTAGAGTATCTTCTCAAAAGTTGGAA-3′
5′-GGCGAATTCTCACCCCTGCACCCATGG-3′
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PMSF, 1 mM benzamidine, 2 mM sodium molybdate, 2 mM sodium β-
glycerophosphate, 0.2 mM sodium orthovanadate, 120 mM KCl, 1 μg/ml
leupeptin and pepstatin A, and 10 μg/ml antipain). Cells were lysed in the same
buffer containing 0.5% NP-40 and 0.1% Triton X-100 (50 μl/106 cells). Cell
lysates were centrifuged at 12,000 g for 10 min and the supernatants were stored
at −80 °C. Protein was measured by the Bradford method [28].
2.3. Analysis of eIF4E phosphorylation state
To determine eIF4E phosphorylated levels in vivo, transfected cell lysates
were resolved by horizontal isoelectric focusing (IEF) in slab gels and analyzed
by immunoblotting as described [29]. Blots were incubated with the monoclonal
anti-eIF4E antibody (BD Biosciences) and developed with alkaline phosphatase
reagents. Alternatively, lysates were resolved by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and sequentially developed
with anti-phosphorylated eIF4E (Ser209) (Cell Signaling Technology) and
monoclonal anti-eIF4E antibodies as above. Stained bands were scanned and
quantified with an analyzer equipped with the software package ImagequantTL
(Amersham Biosciences).
2.4. Immunolocalization
HEK293Tcells were cultured on glass coverslips and transiently transfected.
After 24 h of transfection, cells were fixed with 4% formaldehyde in PBS for
10 min, permeabilized in ethanol/acetic acid (19:1, v/v) for 10 min at −20 °C,
and stained with anti-c-Myc (9E10) (Santa Cruz Biotechnology) diluted 1/50
(v/v). Afterwards, the coverslips were incubated with fluorescein-conjugated
antimouse-IgG (Boehringer-Mannheim) for 1 h and mounted on slides in
glycerol buffer containing p-phenylenediamine and 30 μM bis-benzimide
(Hoechst 33342). Controls were made by omitting the primary antibody and with
untransfected HEK293T cells. Subcellular localization of proteins was assessed
by fluorescence microscopy (Olympus BX 51, objective 40×).
2.5. In vitro kinase assay
In vitro Mnk activity with recombinant eIF4E (reIF4E) as substrate was
assayed as described [5]. When myelin basic protein (MBP, Sigma) was used as
substrate, cell lysates (200 μg) were pre-cleared for 1 h with protein G-sepharose
(50%) before anti-Myc immunoprecipitation. Moreover, the beads were washed
with 1 ml of ice-cold RIPA buffer before the wash with LiCl. From the last
washing with kinase buffer, 1/10 of volume was removed, resolved by SDS-
PAGE and immunoblotted with a monoclonal horseradish peroxidase (HRP)
conjugated anti-c-Myc antibody (Santa Cruz Biotechnology). The kinase
activity was measured with 5 μg of MBP as substrate and in the absence or in the
presence of 10 μM CGP57380 (a gift from Dr. H. Gram, Novartis Pharma,
Basel) as described elsewhere. Kinase reactions were stopped by mixing with 3×
Laemmli buffer, subjected to SDS-PAGE (15% polyacrylamide gel) and
autoradiography or visualized on a PhosphorImager (Amersham Biosciences).
Bands were scanned and quantified as described above. The kinase activity was
normalized to the amount of Myc-Mnks precipitated on the assay.
2.6. In vivo and in vitro phosphorylation
To measure in vivo Mnks phosphorylation, cell lysates were subjected to
SDS-PAGE and immunoblotting as described above. For in vitro phosphoryla-
tion of the Mnks by p38 MAPK, lysates were obtained from HEK293T cells
previously transfected with the different plasmids and Myc-Mnks were purified
from 100 μg of cell lysates by immunoprecipitation with anti-c-Myc as
described above. The beads were incubated in the absence or presence of 0.4 mU
of recombinant p38 MAPK (Upstate) in kinase buffer (20 mM HEPES–KOH,
pH 7.4, 10 mMMgCl2, 1 mM DTT) containing 1 mM ATP at 30 °C for 1 h. The
reaction was stopped with 3× Laemmli buffer and lysates were subjected to
SDS-PAGE and immunoblotting. Phosphorylated Mnks were visualized with a
specific antibody against phosphorylated Thr197/Thr202 of Mnk1 (Cell
Signaling Technology) and total levels of Mnks were determined using anti-c-
Myc antibody.2.7. eIF4G binding to Mnk1
HEK293T cells were cotransfected with pcDNA3-HA-extended eIF4GI
(isoform I of the translation initiation factor eIF4G) [30] (a gift from Dr. F.
Gebauer and Dr. R. Cuesta, Centre de Regulacio Genomica, Barcelona, Spain)
and the different Myc-Mnks plasmids as described above, and lysed with buffer
4G (20 mM Tris–HCl pH 7.6, 2 mM EDTA, 1 mM PMSF, 1 mM benzamidine,
50 mM sodium fluoride, 0.5 mM sodium orthovanadate, 1 μg/ml leupeptin,
pepstatin A, and antipain, 14 mM β-mercaptoethanol, and 1% Triton X-100).
The eIF4G-bound to Mnk1 were purified by immunoprecipitation of Myc-Mnks
as described [31]. Briefly, 100 μg of cell lysates were incubated for 2 h with
30 μl of anti-Myc-agarose (Sigma) presaturated with 1 mg/ml cytochrome c in
buffer 4G. The beads were washed five times with 0.5 ml of the same buffer and
the proteins were eluted with SDS sample buffer and the complex detected by
immunoblot analysis and quantified as above.
3. Results
3.1. Analysis of the eIF4E kinase activity of the different Mnk1a
and Mnk1b mutants
The main aim of this study was to determine the specific
features of Mnk1b relative to Mnk1a. For this purpose, we have
generated several mutants, listed in Fig. 1, in both Mnk1a and
Mnk1b isoforms in order to analyze the effect of these mutations
on their activities.
As we have described previously, the high activity of Mnk1b
would seem to be independent of the activation loop
phosphorylation [5]. Thus, human Mnk1b is much more active
to phosphorylate eIF4E than human Mnk1a in spite of the lower
level of phosphorylation of the residues of the activation loop in
basal conditions [5]. To assess the importance of these residues
in both Mnk1a and Mnk1b, we made mutations of the two Thr
of the activation loop to Ala (T2A2) to obtain a non active
kinase and also converted these Thr to Asp (T2D2), which in
many cases mimic Ser or Thr phosphorylation. The top of Fig.
2A shows the activation loop sequence of both Mnks in which
the canonical Thr–Pro motifs are indicated. In order to
determine the activity of the different constructs, HEK293T
cells were transfected with the different mutants and eIF4E
phosphorylation status was determined. As shown in Fig. 2A,
none of the mutations in the activation loop of both Mnk1a and
Mnk1b showed a higher eIF4E kinase activity than wild type
Mnk1a/b. Actually, Mnk1b mutants T2A2 and T2D2 strongly
lose the kinase activity for eIF4E.
Moreover, given that Mnk1a is 77 amino acid residues longer
than Mnk1b, we deleted the last 77 residues of the C-terminal
Mnk1a sequence to generate a newmutant,Mnk1aΔ77, which is
as short as Mnk1b but differs in the 12 amino acid residues of
Mnk1bSR (Fig. 2B). This mutant lacks the NES and the MAP
kinase binding domain, LARRR, as well (Fig. 1). Moreover, we
generated a mutant which lacked also the Mnk1bSR, named
Mnk1aΔ89, and analyzed its activity (Fig. 1). As shown in Fig.
2B, the mutant Mnk1aΔ77 has much lower eIF4E kinase
activity than Mnk1b supporting that the presence of a shorter
C-terminal tail is not responsible for its high activity. More-
over, this finding suggests a key role for the Mnk1bSR domain
on Mnk1b activity. Similar results were obtained with the
Mnk1aΔ89 mutant, but taking into account that it showed low
Fig. 1. Constructs used in the study. Schematic representation of the Mnk1a and Mnk1b mutants showing the nuclear localization signal (NLS), the nuclear export
signal (NES), the MAP kinase binding domains and the Mnk1b specific region (Mnk1bSR) sequences as an inlet. Activation loop phosphorylation residues are located
into the kinase domain.
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obtained with this mutant are in agreement with those from
Fukunaga et al. [3] showing that the deletion of the C-terminal
(91 amino acid residues, including Thr344) prevented activation
of Mnk1a. In view of this, we decided to eliminate this mutant in
further assays.
The position 344 in human Mnk1a corresponds to Thr,
while it is Ala in Mnk1bSR (Fig. 2C, Top). This residue has
been described as one of the major sites phosphorylated by
ERK1 both in vitro and upon treatment with 12-O-tetradeca-
noylphorbol-13-acetate (TPA) in vivo [3]. Supporting the
important role for the phosphorylated Thr344 in Mnk1a
activation is the fact that the change of this Thr to Glu
activates the kinase [32]. In mouse Mnk1, this residue is
conserved at the position 332 and its replacement with an
acidic residue, as an Asp, also activates the kinase [33,34].
Surprisingly, in mouse Mnk1, the replacement of Thr332 with
Ala did not completely inactivate Mnk1, but caused a partial
activation [33]. Given the importance of the residue in position
344 and, in spite of the different sequence of this region
(Mnk1bSR), we decided to generate mutants changing this Ala
to Thr (A344T) or Asp (A344D) to study the effect of these
mutations on Mnk1b activity (Fig. 1). As shown in Fig. 2C, the
mutation Mnk1bA344D resulted in an inactive eIF4E kinase,
while the mutation Mnk1bA344T rendered an eIF4E kinase as
active as wild type Mnk1b.
To reinforce the results obtained from the in vivo assays, the
different Myc–Mnk proteins purified from lysates of cells
previously transfected with the different plasmids were
incubated with recombinant eIF4E (reIF4E) and [γ-32P]ATP
in vitro. As shown in Fig. 2D, we confirmed that only the wild-type Mnk1b and Mnk1bA344T phosphorylated reIF4E sig-
nificantly. The phosphorylation status of the Thrs of the
activation loop of the different Myc–Mnk proteins was also
analyzed using antibodies specific against phosphorylated
threonines of Mnk1. As shown in top of Fig. 2D, Thr209/
Thr214 in Mnk1b are phosphorylated but at a lower extent than
in Mnk1a. As expected, mutants that affected the activation
loop residues (T2A2 and T2D2) of Mnk1a/b were not
phosphorylated at all. Regarding to the C-terminal mutants,
we could only detect phosphorylation of the T-loop in the
Mnk1bA344T mutant.
3.2. The activity of the different mutants of Mnk1a and Mnk1b
depends on its substrate
We decided to analyze Mnk activity using another substrate,
the myelin basic protein (MBP). Since MBP is a non-specific
substrate for other protein kinases, it was important to use more
stringent washes to remove the protein kinases that can interact
non-specifically with the beads. In addition, we have performed
the kinase assay in the presence or in the absence of CGP57380,
a specific inhibitor of Mnk1a [34,35]. First, we have tested
whether CGP57380 is able to inhibit Mnk1b. For this purpose,
HEK293T cells previously transfected with Mnk1b were treated
with increased amounts of CGP57380 for 1 hr and eIF4E
phosphorylation status was analyzed in cell extracts. As shown
in Fig. 3A, CGP57380 strongly inhibited eIF4E phosphoryla-
tion from 10 to 20 μM, indicating that CGP57380 is a good
inhibitor of Mnk1b activity as well. Surprisingly, the decrease in
Mnk1b activity induced by CGP57380 was accompanied by an
increase in T-loop phosphorylation of 1.4- to 1.5-fold (Fig. 3A,
Fig. 2. Analysis of the eIF4E kinase activity of the different Mnk1a and Mnk1b mutants. 50 μg of lysates from cells transfected with plasmids coding for Mnk1a and
Mnk1b mutants in the activation loop (A), the deletion mutants (B) or in Mnk1bSR (C) were subjected to IEF, transferred to a PVDF membrane and bands
corresponding to eIF4E and phosphorylated eIF4E (eIF4EP) were detected with a specific antibody against eIF4E. The results are expressed as the percentage of
phosphorylated eIF4E with respect to total eIF4E and represent the mean±SEM of four different cultures. Lysates were also immunoblotted with anti-c-Myc antibody
to check the expression levels of the different Mnks. Representative blots are shown at the top of the bar diagram. The sequence of human Mnk1 activation loop and
Mnk1bSR and the corresponding aminoacids in Mnk1a are shown at the top of panels A and C, respectively. Statistical significance: ⁎pb0.05, ⁎⁎pb0.01, versus
control; bpb0.01, cpb0.05, versus Mnk1b transfected cells. (D), 35 μg of lysates from cells transfected with the different Mnk1 plasmids were analyzed by immunoblot
with anti-phosphorylated Thr197/Thr202 of Mnk1 (Cell Signalling Technology) (upper panel). In vitro Mnk activity was assayed as described in Materials and
methods with recombinant eIF4E (reIF4E) and [γ-32P] ATP. Incorporation of 32P-labeled phosphate into eIF4E was visualized by SDS-PAGE and autoradiography
(lower panel). 1/10 of the immunoprecipitates was immunoblotted with anti-c-Myc antibody (middle panel). Key: C, cells transfected with empty vector.
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SB203580 or U0126, strongly inhibited Mnk1b phosphoryla-
tion in Thr209/Thr214 but having slight effect on eIF4Ephosphorylation when used each one separately. This effect
was clearly enhanced when both inhibitors were used together
(a decrease of 64% in phosphorylated eIF4E levels).
Fig. 3. MBP phosphorylation by the different mutants of Mnk1a and Mnk1b. (A) Assay addressed to establish the Mnk1 inhibitor (CGP57380) concentration able to
inhibit Mnk1b activity. Cells previously transfected with Mnk1b were treated with CGP57380 (5 μM, 10 μM, 20 μM, 30 μM and 40 μM), U0126 (50 μM), SB203580
(20 μM) or U0126/SB203580 for 1 h before harvesting. Cell lysates (35 μg) were analyzed by immunoblot with anti-phosphorylated Thr197/Thr202 of Mnk1 or anti-
phosphorylated Ser209 of eIF4E antibodies (Cell Signalling Technology) as described in Materials and methods. Next, blots were reprobed with anti-c-Myc or anti
eIF4E antibodies, respectively. The results were quantified as described in Materials and methods and expressed as the ratio of phosphorylated Mnk1b with respect to
Myc signal. The value of phosphorylated Thrs of Mnk1b in the absence of inhibitors was set at 1. The bars represent the mean±SEM of three different experiments. (B)
In vitro Mnk activity was assayed with MBP as substrate as described in Materials and methods. Upper panel, incorporation of 32P-labeled phosphate into MBP was
visualized by SDS-PAGE (15% polyacrylamide gel) and autoradiography. Lower panel, total MBP in the gel was stained with Coomassie brilliant blue. 1/10 of the
beads were subjected to SDS-PAGE (12% polyacrylamide gel), developed with anti-c-Myc antibody, and quantified (panel under bar graphs). The intensity of
phosphorylated MBP was quantified, the value obtained for the cells transfected with empty vector (C) subtracted of each sample and Mnk activity was calculated as
the difference between MBP-phosphorylating activity in the absence and the presence of 10 μM CGP57380. Data were normalized to the Myc signal and the values
obtained for Mnk1a considered being 1. The bars represent the mean±SEM of three different experiments.
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Myc–Mnks were purified from lysates of cells previously
transfected with the different plasmids and incubated with
MBP and [γ-32P] ATP in vitro in the absence or presence of
CGP57380 at 10 μM. As shown in Fig. 3B, the control sample
immunoprecipitated from cells transfected with empty vector
showed a very low MBP kinase activity that was only slightly
inhibited with CGP57380 (b20%). This background was
subtracted of each sample and Mnk activity was calculated as
the difference between MBP-phosphorylating activity in the
absence and the presence of CGP57380. The activity of
Mnk1a was considered as 1, and the values of the different
Mnks normalized with respect to Mnk1a activity. As shown in
Fig. 3B (bar graphs), the ability of the mutants Mnk1aT2A2,
Mnk1bT2A2 and Mnk1bA344T to phosphorylate MBP
decreased markedly compared with that of wild-type Mnk1a
(0.4, 0.7 and 0.05-fold, respectively) whereas Mnk1aT2D2
kinase activity did not change (1.1-fold). Mnk1b, Mnk1bT2D2
and Mnk1bA344D exhibited similar activity (about 3-fold)
and Mnk1aΔ77 was about 2-fold more active than Mnk1a
phosphorylating MBP.
Under basal conditions, the mutation A344D resulted in an
inactive eIF4E kinase, while the mutation A344T produced a
mutant which phosphorylated eIF4E to an extent similar to
wild-type Mnk1b (Fig. 2). However, the ability of these mutants
to phosphorylate MBP is reversed (Fig. 3B). Thus, it seems that
the change of Ala to Thr or Asp could induce some structural
modification that drives the enzyme to interact more efficiently
with one or other substrate. Up to date, it has been demonstrated
that Mnk must bind eIF4G to phosphorylate efficiently eIF4E
[17]. We have therefore decided to study the interaction of wild
type and C-terminal mutants of Mnk1a and Mnk1b with eIF4G
by co-immnunoprecipitation. In view that our efforts to detect
endogenous eIF4G bound to Mnk1b failed, cells were co-
transfected with different Mnks constructs or the empty-vector
and HA-eIF4GI, and the interaction assayed by co-immuno-
precipitation using anti-Myc-agarose beads. The results show
that only Mnk1a and Mnk1bA344D, which does not phosphory-
late eIF4E, were able to bind to eIF4G (Fig. 4). These results
are consistent with the previous paper reporting that there is an
inverse relationship between Mnk activity and eIF4G binding
[36].Fig. 4. Binding of eIF4G to Mnks. HEK293T cells were cotransfected with HA-eIF4
were lysed in 4G buffer and Myc–Mnks immunoprecipitated with anti-c-Myc-agaro
coimmunoprecipitated eIF4G were determined by immunoblot with anti-c-Myc and
immunoblot to check the expression levels of the different Mnks and HA-tagged eI3.3. Subcellular localization of the Mnk1a and Mnk1b mutants
Previously, we have shown that human Mnk1a and Mnk1b
have different subcellular localization, Mnk1a being cytoplas-
mic while a substantial fraction of Mnk1b was found in the
nuclear compartment [5]. We used indirect immunofluores-
cence analysis to test if there were changes in the subcellular
localization of the different human Mnk1 mutants relative to
wild-type Mnk1a and Mnk1b. Nuclear staining was also
determined by a confocal microscope and Hoechst 33342
(data not shown). As expected, in transfected HEK293T cells,
Mnk1a is largely cytoplasmic while Mnk1b was present in
both cytoplasm and nuclei (Fig. 5A). As shown in Fig. 5B,
mutations of the phosphorylable residues of the activation
loop did not affect significantly the subcellular distribution of
the mutant Mnks with respect to wild-type Mnks. However,
the percentage of cells containing either Mnk1bT2A2 or
Mnk1bT2D2 mutants predominantly in the nucleus was higher
than that found with wild-type Mnk1b (about 3-fold). When
analyzing the subcellular localization of both Mnk1bA344T
and Mnk1bA344D mutants, the staining is mainly perinuclear
in those cells that show nuclear staining (Fig. 5C) which
suggests that these proteins could be passing through the
cytoplasm to the nucleus. This distribution pattern has been
previously observed for mouse Mnk1 and eIF4E upon
stimulation of transfected NIH3T3 cells with TPA [33].
Regarding to Mnk1aΔ77 (Fig. 5D), it is important to be
aware that the cells presented Mnk1aΔ77 in the nucleus,
indicating that the lack of the C-terminal tail containing the
NES is important for the exit of the kinase from the nucleus to
the cytoplasm as previously demonstrated for mouse Mnk1
[6].
3.4. MAP kinases phosphorylate the activation loop residues of
Mnk1b and the C-terminal mutants.
As it can be observed in Fig. 2D, the phosphorylation of
the activation loop residues in Mnk1a is higher than in
Mnk1b in the basal conditions whereas eIF4E kinase activity
is lower. Upon in vivo TPA activation Mnk1a phosphoryla-
tion in the threonines of the activation loop increased but not
in Mnk1b (Fig 6A). When the eIF4E kinase activity ofGI and Mnk1a, Mnk1b or the C-terminal mutants as indicated. After 24 h, cells
se as described in Materials and methods. The amount of Myc–Mnks and the
anti-HA antibodies respectively (left panel). Lysates (15 μg) were analyzed by
F4G (input, right panel). Blots are representative of two different experiments.
Fig. 5. Subcellular localization of the Mnk1a and Mnk1b mutants. HEK293T cells were transfected with the different Mnk1 plasmids. After 24 h, cells were fixed,
permeabilized and incubated with the anti-c-Myc antibody followed by fluorescein-conjugated antimouse-IgG. Wild-type Mnk1a and Mnk1b (A), Mnk1a and Mnk1b
mutants in the activation loop (B), Mnk1bSR mutants (C) and the Mnk1aΔ77 deletion mutant (D).
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analyzed, we observed that the extent of eIF4E phosphoryla-
tion by human Mnk1a was always lower than that obtained
with Mnk1b (Fig. 6A, bottom panel). In view of this result,
we decided to study whether the treatment with TPA stimu-
lates the kinase activity of Mnk1a/b using another substrate.
Thus, when Mnk1a or Mnk1b were purified from cells treated
with TPA and kinase activity was assayed using MBP as
substrate, we observed that activated Mnk1a phosphorylated
MBP more efficiently than Mnk1b. In fact, Mnk1b activity
decreased 50% after TPA treatment with respect to unstimu-
lated cells (Fig. 6B).
In order to verify the phosphorylation status of the different
mutants of Mnk1a and Mnk1b by MAPK in vivo, HEK293T
cells were transfected with the different constructs andstimulated with TPA. As shown in Fig. 6C, the level of phos-
phorylation in the activation loop residues of Mnk1bA344T
was similar to that observed in Mnk1b. Moreover, phosphory-
lated Mnk1aΔ77 was detected after TPA treatment. Activated
ERK1/2 blot is shown as a control of the activation by TPA (Fig.
6C, bottom panel).
Next, we performed an in vitro kinase assay in which we
incubated Myc–Mnks immunoprecipitated from cells trans-
fected with wild-type Mnks, Mnk1bA344T, Mnk1bA344D
and Mnk1aΔ77 mutants with recombinant p38 MAP kinase.
As shown in Fig. 6D, independently of the basal phos-
phorylation status of the activation loop residues of the
different Mnks, recombinant p38 MAPK is able to phos-
phorylate all the forms (wild type and mutants) of Mnk1a
andMnk1b after 1 h of incubation but, interestingly, Mnk1aΔ77
Fig. 6. Phosphorylation of the activation loop residues of Mnk1a and Mnk1b mutants upon p38 MAPK and/or ERK1/2 activation. (A) HEK293T cells previously
transfected with plasmids encoding Mnk1a, Mnk1b or empty vector were treated with TPA before harvesting. Lysates (35 μg) from cells transfected were analyzed by
immunoblot with anti-phosphorylated Thr209/Thr214 of Mnk1 (upper panel). In vitro Mnk activity was assayed as described in Materials and methods with
recombinant eIF4E (reIF4E) and [γ-32P]ATP. Incorporation of 32P-labeled phosphate into eIF4Ewas visualized by SDS-PAGE and autoradiography (lower panel). 1/10
of the immunoprecipitates was immunoblotted with anti-c-Myc antibody (middle panel). (B) kinase activity measurement using MBP as substrate was performed as in
Fig. 3B, subjected to SDS-PAGE (15% polyacrylamide gel) and autoradiography. The value obtained for the cells transfected with empty vector (C) was subtracted from
each sample andMnk activity was calculated as the difference betweenMBP-phosphorylating activity in the absence and the presence of 10 μMCGP57380. Data were
normalized to the Myc signal and the values obtained for Mnk1a considered being 1. Bars represent the mean±SEM of three different experiments. (C) HEK293Tcells
were transfected with the different constructs and treated with TPA (500 nM) for 30 min before harvesting. Cell lysates were subjected to SDS-PAGE (15%
polyacrylamide gel) and sequentially developed with anti-phosphorylated Thr197/Thr202 of Mnk1, anti-c-Myc and anti-ERKdiP (Sigma) antibodies. Blots are
representative of two different experiments. (D) phosphorylation of Thr209/214 by rp38 MAPK in cells transfected with the different plasmids. Cell lysates (100 μg)
were immunoprecipitatedwith anti-c-Myc antibody and half of the immunoprecipitate was incubatedwith p38MAPK (0.4mU)whereas the other half of the samplewas
incubated in parallel without p38 MAPK as described in Materials and methods. After 1 h of incubation, kinase reactions were stopped with 3× Laemmli buffer,
subjected to SDS-PAGE (12% polyacrylamide gel), and sequentially developed with anti-phosphorylated Thr197/Thr202 of Mnk1, and anti-c-Myc antibodies. A
representative experiment of three that gave similar results is shown. Key: C, cells transfected with empty vector.
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Mnks. Taken together these findings, we can conclude that
MAP kinases phosphorylate Mnk1b in the activation loop
residues in spite of the lack of the MAP kinase binding domain,
LARRR.4. Discussion
We have previously identified a new isoform of the MAP
kinase activated protein kinase Mnk1, named Mnk1b, which is
produced by a splice variant of the human Mnk1 gene [5]. The
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Mnk1b which produce differences in its activity relative to
Mnk1a, i.e. it is a much more active eIF4E kinase under basal
conditions than Mnk1a.
Several reports established that two phosphorylable residues
in the activation loop of the Mnks, Thr197/Thr202 for mouse
Mnks, which correspond to Thr209/Thr214 in human Mnks, are
very important for the kinase activity [2,37]. As we have
described previously, the high basal eIF4E kinase activity of
Mnk1b seems not to correlate with the phosphorylation of the
activation loop residues being Mnk1b much more active than
human Mnk1a on spite of the low phosphorylation of these
residues [5]. To assess the importance of these residues in
Mnk1b activity, we made mutations of both Thr209 and Thr214
of the activation loop of Mnk1a and Mnk1b. The change of both
Thr residues of the activation loop of Mnk1a to Ala gave a non-
active kinase. This result was expected for Mnk1a because, as a
rule, the change of phosphorylable residues of the kinase
catalytic domain for Ala gives an inactive kinase. In addition,
the change of Thr to Asp in many cases mimics Thr
phosphorylation and, generally, gives a constitutively active
kinase. In our case, we found that both mutants lost the eIF4E
kinase activity. This result was in agreement with those
described earlier for mouse Mnk1, in which the authors
suggested that the introduction of an acidic residue does not
substitute functionally the phosphorylation of these sites
[33,37]. However, the lack of the eIF4E kinase activity of the
Mnk1b mutants T2A2 and T2D2 was surprising given that
Mnk1b activity would seem to be independent of the activation
loop phosphorylation [5]. Interestingly, when we analyzed the
kinase activity of the activation loop Mnk1b mutants using
MBP as substrate we observed that the change Thr to Asp
produced an active kinase indicating that the catalytic site of the
enzyme was not affected. From these observations we conclude
that mutations of the threonines to aspartic acid in the activation
loop could affect the affinity and/or specificity of the Mnks for
their different substrates.
The fact that the mutation of the Thrs of the activation loop to
Ala in Mnk1b abrogates its activity suggests that this phos-
phorylation is necessary for the kinase activity. Other findings
supporting this conclusion are (i) that the phosphorylation of the
residues in the activation loop in basal conditions was only
detectable in themutantwith eIF4E kinase activity,Mnk1bA344T
and (ii) the MAP kinases inhibitors induce the dephosphory-
lation of these residues which run in parallel to a decrease in
the eIF4E phosphorylation in vivo in cells transfected with
Mnk1b.
Relative to Mnk1aΔ77, the fact that this mutant has much
lower eIF4E kinase activity than Mnk1b indicates that the
presence of a shorter C-terminal tail in Mnk1b is not responsible
of its higher activity for this substrate. Given that the amino acid
sequence of Mnk1bSR (EQQHNGPDALRS) is completely
different from that of Mnk1aΔ77 (QAPEKGLPTPQV) (Fig.
2C), it seems the nature of these 12 amino acid residues could
play a potential role in the kinase activity. Moreover, our results
and those from Fukunaga et al. [3], showing that mutants
lacking also Mnk1bSR (Mnk1aΔ89 and Mnk1aΔ91) did nothave activity both in basal conditions or after MAPK activation
strongly support the role of Mnk1bSR in the Mnk1b activity.
However, when we analyzed the kinase activity of Mnk1aΔ77
using MBP as substrate, we observed that it produced an active
kinase indicating that the catalytic site of the enzyme was not
affected. Moreover, the ability of Mnk1aΔ77, purified from
cells stimulated with TPA, to phosphorylate MBP was increased
with respect to the basal conditions (T. Jurado, V.M. González
and M.E. Martín, unpublished results) suggesting that the
phosphorylation of this mutant by MAP kinases is responsible
for its activity.
All the above results confirm the importance of the Mnk1b-
specific region, Mnk1bSR. In this region, the residue in the
position 344 is a Ala in Mnk1b that corresponds to a Thr in
human Mnk1a which has been described as one of the major
phosphorylation sites [3]. As we show in Results, the change of
the Ala344 to Thr (the original residue of Mnk1a) did not affect
the activity of Mnk1b to phosphorylate eIF4E. However, the
change of the Ala to Asp renders a non-active eIF4E kinase.
These findings seem to exclude the participation of the
phosphorylation at this residue in the eIF4E kinase activity.
Conversely, the ability of these mutants to phosphorylate MBP
is inverted suggesting that the nature (neutral or negatively
charged) of the residue in position 344 could determine the
affinity and/or specificity of the enzyme for the substrate.
Among other typical mechanisms of substrate recruitment
[38], the binding of the kinase and substrate to the same
scaffolding protein (a variation of this mechanism is the ligand-
induced dimerization of protein kinases) [39], or the co-
localization of the enzyme and the substrate to a small subregion
of the cell had been included [40]. Up to date, a requirement for
Mnks to phosphorylate eIF4E efficiently is its binding to the
scaffolding protein eIF4G [17]. However, we have shown that
the amount of eIF4G bound to Myc–Mnk1a is higher than
Mnk1b. Moreover, the mutation changing the Ala344 to Asp,
that gave a non-active eIF4E kinase, induced an increased
association of Mnk1b with eIF4G. This result was in agreement
with those reporting that the extent of association of Mnks with
eIF4G is dependent of its activation level, i.e. less active Mnks
bind better to eIF4G [31,36,37]. These authors suggest that
interaction of the Mnks with eIF4G when its activity is low
could facilitate the rapid eIF4E phosphorylation following Mnk
activation. Consequently, the decreased association of the
activated Mnks with eIF4G could serve to limit the extent of
the eIF4E phosphorylation.
The binding of eIF4G may regulate the ability of the Mnks to
phosphorylate eIF4E but however, it is also possible that Mnks
function in an eIF4G independent manner. Thus, Jauch et al. [8]
have observed in the Mnk2 crystal structure that neighboring
molecules insert their activation segments into the C-terminal
lobe of the symmetry mate, maintaining conserved polar
interaction between subdomains. Furthermore, these authors
have also reported the crystal structure of the human Mnk1
catalytic domain (residues 39–335) revealing that in nonpho-
sphorylated Mnk1 the activation segment is converted in an
autoinhibitory module. In our opinion, these reports provide
two possibilities to explain Mnk1b activity. First, through of
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its activation segment into the C-terminal lobe of the other one
blocking the autoinhibitory conformation, and second, in which
Mnk1bSR could disrupt the positioning of the activation
segment into the autoinhibitory module maintaining an
activated state of the enzyme. Nevertheless further experiments
are necessary to test these possibilities.
Altogether our findings show that the extent of eIF4E
phosphorylation by human Mnk1a was always lower than that
obtained with Mnk1b even upon stimulation, providing
evidence that eIF4E is a better substrate for Mnk1b than for
Mnk1a. Although the more studied substrate for all the Mnks
has been eIF4E but with different efficiency [2,5,33,37], other
additional substrates have been reported as phospholipase A2
[25] and hnRNPA1 [26]. This might explain the requirement of
the cell to have so many isoforms and splice variants in humans
(Mnk1a, Mnk1b, Mnk2a, and Mnk2b). In addition, the Mnks
have been implicated in several processes such as inflammation
[26,41], growth control [42], viral translation [43] and
proliferation or invasiveness of cancer [24]. The potential
contribution of the different isoforms of Mnk to these processes
has to be established.
In summary, in this paper we conclude (i) that although the
activity of Mnk1a and Mnk1b does not correlate with the
phosphorylation status of the activation loop residues, these
threonines are necessary for Mnk1b being active; (ii) the fact
that Mnk1b lacks 77 amino acids in the C-terminal end relative
to Mnk1a does not justify its high eIF4E kinase activity; and
(iii) the sequence of 12 aminoacids in the C-terminal region of
Mnk1b (Mnk1bSR), among them the alanine at the position
344, is important for its kinase activity.
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